India Targeted Drug Delivery Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the India Targeted Drug Delivery Market was valued at USD 301.0 million in 2025 and is projected to reach USD 461.64 million by 2032, growing at a CAGR of approximately 6.3% during 2026–2032.
India Targeted Drug Delivery Market Highlights
| Report Metric | Details |
| Report Name | India Targeted Drug Delivery Market |
| Market Size 2025 | USD 301.0 million |
| Market Size 2032 | USD 461.64 million |
| Absolute Growth 2025–2032 | USD 160.64 million |
| CAGR 2026–2032 | 6.3% |
| Peak Annual Growth | 7.5% in 2026 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Delivery System Type, 2025 | Nanoparticle Systems (42% share) |
| Leading Carrier Material, 2025 | Liposomes/Polymers (43% share) |
| Leading Target Site, 2025 | Tumor Cells (50% share) |
| Leading End User, 2025 | Pharmaceutical Firms (45% share) |
| Fastest-Growing Delivery System Type | Antibody-Drug Conjugates (9.1% CAGR) |
| Fastest-Growing Carrier Material | Monoclonal Antibodies (8.1% CAGR) |
| Fastest-Growing Target Site | Cancer Cells (7.8% CAGR) |
| Fastest-Growing End User | Biotech Companies (8.0% CAGR) |
| Growing Sector | Pharmaceuticals |
| Key End Users | Pharmaceutical Firms, Biotech Companies, Hospitals |
India Targeted Drug Delivery Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
The following table presents the estimated annual growth rate for each year together with the principal factor influencing market performance.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 4.7 | The market showed steady demand for advanced therapies amid rising healthcare needs. |
| 2023 | 7.3 | Growth accelerated due to increased research funding and healthcare investments. |
| 2024 | 4.4 | The market experienced a slowdown as competition intensified among drug delivery systems. |
| 2025 | 3.8 | Growth decelerated further as the National Health Mission began to improve healthcare access. |
| 2026 | 7.5 | Demand surged again with the introduction of new therapies and technologies. |
| 2027 | 6.4 | A slowdown occurred as regulatory approvals for new products faced delays. |
| 2028 | 7.3 | Growth picked up as more hospitals adopted targeted therapies for cancer treatment. |
| 2029 | 6.0 | The market slowed as healthcare budgets faced constraints in some regions. |
| 2030 | 4.5 | Growth is projected to decelerate due to increasing competition and market consolidation. |
| 2031 | 5.8 | Demand is expected to rise as pharmaceutical firms expand their research capabilities. |
| 2032 | 6.6 | The market is anticipated to grow as new technologies emerge and healthcare access improves. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
India Targeted Drug Delivery Market Synopsis
Targeted Drug Delivery in India encompasses advanced technologies designed to deliver medications directly to specific cells or tissues. This method, primarily involving nanoparticles and antibodies, maximises treatment efficacy while reducing side effects. The India Targeted Drug Delivery Market is expanding due to a substantial patient base, with over 1.3 million cancer patients potentially benefiting from these therapies. Ongoing research and government initiatives, such as the 'Biotechnology Industry Research Assistance Council', are driving demand for new drug delivery solutions.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Growing prevalence of cancer and chronic diseases driving demand for targeted therapies. | Driver | High | Nanoparticle Systems |
| Increased funding for biotechnology research fostering innovation in drug delivery. | Driver | High | Antibody-Drug Conjugates |
| Emerging opportunities in the biotech sector for innovative drug delivery solutions. | Opportunity | High | Biotech Companies |
| Expansion of healthcare facilities in Maharashtra and Gujarat creating demand for advanced therapies. | Opportunity | Medium | Hospitals |
| Regulatory hurdles delaying the approval of new drug delivery systems. | Restraint | High | Implantable Devices |
| Limited awareness and understanding of targeted therapies among healthcare providers. | Restraint | Medium | pH/Temp-Sensitive Systems |
| High development costs for new drug delivery technologies affecting market entry. | Challenge | High | Nanoparticle Systems |
| Competition from traditional drug delivery methods impacting market share. | Challenge | Medium | Antibody-Drug Conjugates |
Evaluation of Drivers in India Targeted Drug Delivery Market (2026–2032)
The table below links each growth driver to the segment it affects and the evidence for it.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Rising cancer patient population increasing demand for targeted therapies. | Nanoparticle Systems | Over 1.3 million cancer patients in India are potential beneficiaries of targeted therapies. |
| Increased investment in biotechnology research driving innovation in drug delivery. | Antibody-Drug Conjugates | The National Institute of Pharmaceutical Education and Research supports research in targeted drug delivery. |
| Growing focus on advanced drug delivery solutions among pharmaceutical firms. | Liposomes/Polymers | The 'Make in India' initiative encourages local production of advanced medical technologies. |
| Expansion of healthcare access through government initiatives boosting demand. | Hospitals | The National Health Mission aims to improve healthcare access, indirectly boosting demand for advanced drug delivery. |
| Rising awareness of targeted therapies among healthcare professionals. | Biotech Companies | The 'Atal Innovation Mission' promotes startups in healthcare, including drug delivery innovations. |
Market growth for Targeted Drug Delivery in India is underpinned by rising cancer patient populations, increased investment in biotechnology research, and expanding pharmaceutical firm capabilities. The patient base includes over 1.3 million cancer patients, driving demand for effective therapies. Support from educational institutions enhances research in drug delivery technologies. These factors collectively create a dynamic environment for innovation and investment in targeted drug delivery systems.
Evaluation of Restraints in India Targeted Drug Delivery Market
The table below lists the restraints and the evidence behind each.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Regulatory hurdles delaying product approvals for new drug delivery systems. | Implantable Devices | The Drug Controller General of India oversees regulations for drug delivery technologies. |
| Limited awareness among healthcare providers about targeted therapies. | pH/Temp-Sensitive Systems | This lack of understanding restricts adoption rates in clinical settings. |
| High development costs for new drug delivery technologies impacting market entry. | Nanoparticle Systems | Developing new systems requires substantial financial investment and resources. |
| Competition from traditional drug delivery methods affecting market share. | Antibody-Drug Conjugates | Established methods remain preferred by some healthcare providers. |
| Market saturation limiting growth opportunities for new entrants. | Liposomes/Polymers | Existing players dominate the market, making it hard for newcomers. |
India Targeted Drug Delivery Market Challenges
Regulatory compliance slows the India targeted drug delivery market, as the Drug Controller General of India enforces strict approval processes that can delay new therapies by up to 12 months, limiting patient access. Technology limitations also hinder progress, with many local manufacturers lacking advanced materials, which restricts their ability to compete effectively. A shortage of skilled professionals in research and development roles stifles innovation, leading to project delays and increased costs for biotech firms. High production costs are another challenge, with manufacturers facing expenses that can exceed 30% compared to international competitors, which pressures pricing strategies for buyers.
Trends in the India Targeted Drug Delivery Market
Several trends are reshaping the India Targeted Drug Delivery Market; the most important are set out below.
- Shift towards Personalized Medicine: India is increasingly adopting personalized medicine approaches in targeted drug delivery, particularly in oncology. The updated National Health Policy in 2022 supports advanced drug delivery systems, promoting tailored therapies for patients.
- Expansion of Biotech Innovations: The 'Startup India' initiative, launched in 2020, is promoting biotech innovations in drug delivery. This programme has allocated substantial funding to support startups, leading to a surge in novel drug delivery technologies.
- Increased Focus on Research and Development: The National Institute of Pharmaceutical Education and Research is enhancing R&D in targeted drug delivery. With over 1.3 million cancer patients in India, research funding is essential for developing effective therapies.
- Growth of Advanced Manufacturing Facilities: Maharashtra and Gujarat are emerging as key regions for pharmaceutical manufacturing in India. With a combined production capacity exceeding USD 100 million, these states are central to the growth of targeted drug delivery.
Investment Opportunities in the India Targeted Drug Delivery Market
Investors looking at the India Targeted Drug Delivery Market should consider the following areas.
- Timing for Investment in Advanced Therapies: With a projected market size of USD 461.64 million by 2032, there is a strong opportunity for investment in targeted drug delivery. Pharmaceutical firms are actively seeking solutions to improve treatment efficacy.
- Expansion in Maharashtra and Gujarat: Maharashtra and Gujarat are key regions for pharmaceutical manufacturing, presenting opportunities for local partnerships. Establishing joint ventures with local firms can facilitate market entry and production.
- Focus on Biotech Startups: The 'Startup India' initiative provides funding for healthcare startups focusing on drug delivery innovations. This presents an opportunity for investors to support emerging companies in the biotech sector.
- Growing Demand for Cancer Treatments: With over 1.3 million cancer patients in India, there is a pressing need for advanced drug delivery solutions. Investing in targeted therapies can meet this demand and improve patient outcomes.
Government Initiatives in the India Targeted Drug Delivery Market
The 'National Biotechnology Development Strategy', launched in 2021 by the Department of Biotechnology, aims to promote biotechnology applications, including targeted drug delivery. This strategy encourages research and development in drug delivery technologies, benefiting producers and buyers alike. The updated 'National Health Policy' in 2022 includes advanced drug delivery systems to improve healthcare access, directly impacting treatment options available to patients.
The 'Biotechnology Industry Research Assistance Council' supports biotech innovations, providing funding for research projects in targeted drug delivery. The Indian Council of Medical Research is also funding studies on targeted therapies for cancer treatment, ensuring that new technologies are developed and implemented effectively. These initiatives improve the capabilities of healthcare providers and enhance access to advanced therapies for patients.
Future Insight of the India Targeted Drug Delivery Market
The India targeted drug delivery market will undergo substantial changes by 2032, driven by the 'Make in India' initiative that encourages local production of advanced medical technologies. Increased funding from the Indian Council of Medical Research for targeted therapies will boost research capabilities and innovation in drug delivery systems. The growth of startups, supported by the Atal Innovation Mission, will bring fresh ideas into the market, fostering competition and improving service offerings. With over 1.3 million cancer patients in need of targeted therapies, the demand for advanced healthcare solutions will continue to rise, prompting suppliers to innovate and expand their offerings.
Market Segmentation Analysis
The report offers a comprehensive study of the following market segments and their leading categories in the market.
By Delivery System Type – Nanoparticle Systems Dominated, Antibody-Drug Conjugates Expected to Grow Fastest
According to Sumit Sagar, AM at 6Wresearch, Nanoparticle Systems took a 42% share of delivery system type in 2025, more than any other category. Nanoparticle systems hold the largest market share as they play a critical role in delivering drugs directly to target sites, which is essential for effective treatment. Their importance is underscored by the needs of over 1.3 million cancer patients in India who benefit from these therapies. Antibody-Drug Conjugates are set to record the highest CAGR in this split, 9.1% over 2026–2032. Antibody-drug conjugates are experiencing rapid growth due to their ability to significantly improve the effectiveness of cancer therapies, with backing from the Indian Council of Medical Research's studies. This focus on targeted therapies will likely accelerate their market adoption further. Suppliers should prioritise the development of antibody-drug conjugates to meet the increasing demand in the targeted drug delivery market.
By Carrier Material – Liposomes/Polymers Dominated, Monoclonal Antibodies Expected to Grow Fastest
Liposomes/Polymers held a 43% share of the India Targeted Drug Delivery Market by carrier material in 2025. Liposomes and polymers hold the largest share in the market as they are extensively used for encapsulating drugs for targeted delivery, making them essential in pharmaceutical applications. Their adaptability in various formulations reinforces their strong presence within the industry. The quickest growth will come from Monoclonal Antibodies, forecast to expand at a CAGR of 8.1% between 2026 and 2032. Monoclonal antibodies are experiencing rapid growth, serving as critical components in targeted therapies for a range of diseases, aligning with the industry's shift towards precision medicine. Their increasing integration into treatment protocols is likely to accelerate market expansion. Buyers should prioritise sourcing monoclonal antibodies to capitalise on advancements in targeted drug delivery technologies.
By Target Site – Tumor Cells Dominated, Cancer Cells Expected to Grow Fastest
The largest target site category in 2025 was Tumor Cells, with a 50% share of total revenue. Tumor cells are the primary target for many targeted delivery systems, which is why they hold the largest market share in this segment. Their significance in oncology treatments drives substantial investments and research efforts. Cancer Cells are projected to grow fastest, at a CAGR of 7.8% during 2026–2032. Cancer cells are the focus of most targeted therapies, leading to rapid growth in this area as healthcare systems prioritise cancer treatment innovations. The increasing prevalence of cancer in India supports this trend. Suppliers must align their strategies with the focus on cancer cell targeting to capture emerging opportunities in the market.
By End User – Pharmaceutical Firms Dominated, Biotech Companies Expected to Grow Fastest
In 2025, Pharmaceutical Firms led the end user split with a 45% share. Pharmaceutical firms capture the largest market share as they are the main developers and users of targeted delivery systems, which drives innovation and application in drug development. Their established infrastructure supports the widespread implementation of these advanced technologies in the healthcare sector. Over 2026–2032, Biotech Companies are expected to post the fastest growth, at a CAGR of 8.0%. Biotech companies are rapidly adopting targeted delivery technologies, innovating treatments that cater to specific patient needs, which is vital in a competitive healthcare landscape. Their nimbleness in research and development plays a key role in this growth. Suppliers should collaborate with biotech companies to enhance their competitiveness in the targeted drug delivery market.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- India Targeted Drug Delivery Market Outlook
- Market Size of India Targeted Drug Delivery Market, 2025
- Forecast of India Targeted Drug Delivery Market, 2032
- Historical Data and Forecast of India Targeted Drug Delivery Revenues & Volume for the Period 2022 - 2032F
- India Targeted Drug Delivery Market Trend Evolution
- India Targeted Drug Delivery Market Drivers and Challenges
- India Targeted Drug Delivery Price Trends
- India Targeted Drug Delivery Porter's Five Forces
- India Targeted Drug Delivery Industry Life Cycle
- Historical Data and Forecast of India Targeted Drug Delivery Market Revenues & Volume By Delivery System Type for the Period 2022 - 2032F
- Historical Data and Forecast of India Targeted Drug Delivery Market Revenues & Volume By Nanoparticle Systems for the Period 2022 - 2032F
- Historical Data and Forecast of India Targeted Drug Delivery Market Revenues & Volume By Antibody-Drug Conjugates for the Period 2022 - 2032F
- Historical Data and Forecast of India Targeted Drug Delivery Market Revenues & Volume By Implantable Devices for the Period 2022 - 2032F
- Historical Data and Forecast of India Targeted Drug Delivery Market Revenues & Volume By pH/Temp-Sensitive Systems for the Period 2022 - 2032F
- Historical Data and Forecast of India Targeted Drug Delivery Market Revenues & Volume By Carrier Material for the Period 2022 - 2032F
- Historical Data and Forecast of India Targeted Drug Delivery Market Revenues & Volume By Liposomes/Polymers for the Period 2022 - 2032F
- Historical Data and Forecast of India Targeted Drug Delivery Market Revenues & Volume By Monoclonal Antibodies for the Period 2022 - 2032F
- Historical Data and Forecast of India Targeted Drug Delivery Market Revenues & Volume By Biodegradable Polymers for the Period 2022 - 2032F
- Historical Data and Forecast of India Targeted Drug Delivery Market Revenues & Volume By Responsive Polymers for the Period 2022 - 2032F
- Historical Data and Forecast of India Targeted Drug Delivery Market Revenues & Volume By Target Site for the Period 2022 - 2032F
- Historical Data and Forecast of India Targeted Drug Delivery Market Revenues & Volume By Tumor Cells for the Period 2022 - 2032F
- Historical Data and Forecast of India Targeted Drug Delivery Market Revenues & Volume By Cancer Cells for the Period 2022 - 2032F
- Historical Data and Forecast of India Targeted Drug Delivery Market Revenues & Volume By Brain/Spinal Regions for the Period 2022 - 2032F
- Historical Data and Forecast of India Targeted Drug Delivery Market Revenues & Volume By Inflammatory Tissues for the Period 2022 - 2032F
- Historical Data and Forecast of India Targeted Drug Delivery Market Revenues & Volume By End User for the Period 2022 - 2032F
- Historical Data and Forecast of India Targeted Drug Delivery Market Revenues & Volume By Pharmaceutical Firms for the Period 2022 - 2032F
- Historical Data and Forecast of India Targeted Drug Delivery Market Revenues & Volume By Biotech Companies for the Period 2022 - 2032F
- Historical Data and Forecast of India Targeted Drug Delivery Market Revenues & Volume By Hospitals for the Period 2022 - 2032F
- Historical Data and Forecast of India Targeted Drug Delivery Market Revenues & Volume By Drug Delivery Startups for the Period 2022 - 2032F
- India Targeted Drug Delivery Import Export Trade Statistics
- Market Opportunity Assessment By Delivery System Type
- Market Opportunity Assessment By Carrier Material
- Market Opportunity Assessment By Target Site
- Market Opportunity Assessment By End User
- India Targeted Drug Delivery Top Companies Market Share
- India Targeted Drug Delivery Competitive Benchmarking By Technical and Operational Parameters
- India Targeted Drug Delivery Company Profiles
- India Targeted Drug Delivery Key Strategic Recommendations
Market Covered
The report offers an extensive study of the following market segments.
By Delivery System Type
- Nanoparticle Systems
- Antibody-Drug Conjugates
- Implantable Devices
- pH/Temp-Sensitive Systems
By Carrier Material
- Liposomes/Polymers
- Monoclonal Antibodies
- Biodegradable Polymers
- Responsive Polymers
By Target Site
- Tumor Cells
- Cancer Cells
- Brain/Spinal Regions
- Inflammatory Tissues
By End User
- Pharmaceutical Firms
- Biotech Companies
- Hospitals
- Drug Delivery Startups
